BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191202
DTEND;VALUE=DATE:20191205
DTSTAMP:20260515T041939
CREATED:20190815T095332Z
LAST-MODIFIED:20190815T095403Z
UID:21972-1575244800-1575503999@www.pharmajournalist.com
SUMMARY:2nd Annual RNA Targeted Drug Discovery
DESCRIPTION:At a time when the previously untapped drug discovery opportunity promised within RNA opens up\, the 2nd RNA- Targeted Drug Discovery Summit returns to reunite the leading minds from large pharma\, innovative biotech and KOLs of academia to discuss unique discovery and development challenges that must be overcome for novel RNA targeted small molecule therapeutics to achieve their seemingly limitless potential. \n \nFor the 2nd year\, network with the KOLs and RNA pioneers\, to gain a comprehensive understanding on how to translate the first generation of RNA targeted small molecules into the clinic\, stimulate the discussion of successfully targeting RNA via interfering with RNA-protein interactions and seize the therapeutic opportunity in hand by re-defining the undruggable nature of RNA. \nDownload the Full Event Guide. \nWith 22 world-class speakers sharing their latest findings\, join those who are re-defining the undruggable nature of RNA: \n\nKevin Weeks\, Founder of Ribometrix; Professor of Chemistrym\, University of North Carolina\nFrank Slack\, Co-Founder of Twentyeight-Seven Therapeutics; Professor\, BIDMC\nKathryn McCabe\, Sr. Director of Business Development\, Eli Lilly\nMartin Pettersson\, Research Fellow\, Pfizer\nChristopher Barbieri\, Senior Investigator\, Bristol-Myers Squibb\nJennifer Petter\, Founder & CSO\, Arrakis Therapeutics\nYochi Slonim\, Co-founder & CEO\, Anima Biotech\nGerhard Mueller\, CSO\, Gotham Therapeutics\nChristopher R. Trotta\, VP\, Biology\, PTC Therapeutics\n\nThis is only some of the senior experts confirmed to present – check out the full speaker faculty and case studies here. \nOnce again join your RNA community at this translational and industry dedicated event focused on optimizing target validation\, improving drug-like properties & accelerating the translation of selective and bioactive RNA targeted small molecule therapeutics into human clinical trials. \nCheck out the official event guide for full speaker details or if you’re ready to register\, secure your place here.
URL:https://www.pharmajournalist.com/event/2nd-annual-rna-targeted-drug-discovery/
LOCATION:The Westin Copley Place\, 10 Huntington Avenue\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191203
DTEND;VALUE=DATE:20191206
DTSTAMP:20260515T041939
CREATED:20190909T090526Z
LAST-MODIFIED:20190909T101000Z
UID:22341-1575331200-1575590399@www.pharmajournalist.com
SUMMARY:Oncolytic Virotherapy Summit 2019
DESCRIPTION:Now in its 5th year\, the Oncolytic Virotherapy Summit is the industry’s definitive guide to turning viral vehicles into clinically effective therapeutics across oncology indications. With 3 days of in-depth cutting-edge case studies and the highest calibre of industry discussions\, The OV Summit will provide the roadmap to oncolytic virotherapy success. \nHear from pharma and biotech companies of all sizes\, as well as clinicians and leading academics for a complete picture of the current challenges and opportunities. Discover the development of oncolytic viruses that engage the immune system for long-term treatment and management of cancers. \nTo learn more and to register online\, visit: http://bit.ly/2kmZGQh
URL:https://www.pharmajournalist.com/event/oncolytic-virotherapy-summit-2019/
LOCATION:Westin Boston Waterfront\, 425 Summer St\, Boston\, MA 02210
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191203
DTEND;VALUE=DATE:20191206
DTSTAMP:20260515T041939
CREATED:20191101T093844Z
LAST-MODIFIED:20191101T093844Z
UID:23150-1575331200-1575590399@www.pharmajournalist.com
SUMMARY:3rd Microbiome Movement – Gut-Brain Axis Summit
DESCRIPTION:The 3rd Microbiome Movement – Gut-Brain Axis Summit is returning to Boston this December and will unite pioneering industry and academic researchers to establish the mechanistic pathways contributing to neurological disorder manifestation\, overcome the scientific and translational challenges of working in the gut-brain setting and capitalize on this therapeutic opportunity. \n \nThis meeting provides the opportunity for you to: \n\nDiscover pioneering preclinical data implicating metabolic\, immune-mediated and enteroendocrine pathways in CNS disease development\nExplore translational approaches that are moving microbiome gut-brain axis science from association to causation\nLearn about critical considerations for microbiome clinical trials in the neurological and mental health setting to inform symptom and treatment management\nRealize the potential of microbial profiles as a biomarker for patient stratification to maximize the efficacy of already existing drugs for neurological disease\nUncover the relatively untapped commercial opportunity held by nutritional and therapeutic products for neurological and mental health\n\nThere is no question that the early market activity in the microbiome gut-brain axis space is critical in shaping its success. Join us to discover the microbiome science contributing to neurological disease and develop the next generation of microbiome-targeted products for improved neurological and mental health outcomes. \nFind out more here: https://ter.li/t9gsy7
URL:https://www.pharmajournalist.com/event/3rd-microbiome-movement-gut-brain-axis-summit/
LOCATION:Boston\, MA
ORGANIZER;CN="Hanson Wade":MAILTO:katie.jacobs@hansonwade.com
END:VEVENT
END:VCALENDAR